
Our new EU GMP-compliant facility in Greece is located in a 9.200 square meters area in the Industrial Zone of Larissa and consists of high-end production lines capable of producing pharmaceutical products in a wide range of oral solid dosage forms with an exceptional annual capacity through a range of manufacturing processes as well as corresponding individualized packaging.
Currently several new generic molecules are manufactured, some of which are projects of innovative formulations based on drug delivery technologies. Using the application of innovative ideas and advanced technologies, Rontis aims to provide challenging and optimized pharmaceutical products to patients.